The Food and Drug Administration is expected to significantly restrict the use of a pair of monoclonal antibody treatments for COVID-19 because they are ineffective against the omicron variant, a senior administration health official confirmed.As a…
Source: The Hill
FDA expected to restrict use of two COVID-19 monoclonal antibody treatments
Published in Make America Late Again
More from Make America Late AgainMore posts in Make America Late Again »
- How U.S. Gas Gives Options to Europe but Increases Pollution Back Home
- “Jus Ex Bello” and the Continued Justice of Ukraine’s Fight Against Russia
- Making Global Ethics More Global
- Psaki, Jean-Pierre absences give others possible at White House audition
- The Memo: Border surge spells trouble for Biden, DemocratsÂ
Be First to Comment